Resveratrol inhibits ovarian tumor growth in an in vivo mouse model

    loading  Checking for direct PDF access through Ovid

Abstract

BACKGROUND

Resveratrol inhibits the growth of ovarian carcinoma cells in vitro through the inhibition of glucose metabolism and the induction of both autophagy and apoptosis. In the current study, we investigated the metabolic and therapeutic effects of resveratrol in vivo.

METHODS

A fluorescent xenograft mouse model of ovarian cancer was used. Mice were treated with cisplatin, resveratrol, or vehicle alone. Tumor burden was assessed using whole-body imaging. The effect of resveratrol on glucose uptake in vivo was determined using micro-positron emission tomography scanning. To determine whether resveratrol could inhibit tumor regrowth, tumor-bearing mice were treated with cisplatin followed by either daily resveratrol or vehicle. Autophagic response in resected tumors taken from mice treated with resveratrol was examined by transmission electron microscopy. Glycolysis and mitochondrial respiration in ovarian tumor cells after treatment with resveratrol was assessed.

RESULTS

Mice treated with resveratrol and cisplatin were found to have a significantly reduced tumor burden compared with control animals (P<.001). Resveratrol-treated mice demonstrated a marked decrease in tumor uptake of glucose compared with controls. After treatment with cisplatin, “maintenance” resveratrol resulted in the suppression of tumor regrowth compared with mice receiving vehicle alone (P<.01). Tumors resected from mice treated with resveratrol exhibited autophagosomes consistent with the induction of autophagy. Treatment with resveratrol inhibited glycolytic response in ovarian tumor cells with high baseline glycolytic rates.

CONCLUSIONS

Treatment with resveratrol inhibits glucose uptake and has a significant antineoplastic effect in a preclinical mouse model of ovarian cancer. Resveratrol treatment suppresses tumor regrowth after therapy with cisplatin, suggesting that this agent has the potential to prolong disease-free survival.

Treatment with resveratrol inhibits glucose uptake and appears to have a significant antineoplastic effect in a preclinical mouse model of epithelial ovarian cancer. Ovarian cancer cells are able to use both glycolysis and oxidative phosphorylation to generate adenosine triphosphate (ATP). Resveratrol treatment suppresses glycolysis in tumor cells with high baseline glycolytic rates. The use of drug combinations that inhibit distinct metabolic pathways may be more effective than monotherapy alone in eliminating cancer cells.

Related Topics

    loading  Loading Related Articles